A global memory-chip shortage is disrupting the tech sector as AI firms, smartphone makers, and electronics companies battle for limited supplies. Prices for DRAM, flash, and HBM have surged, squeezing inventories and pushing up consumer device costs. Experts warn the crunch may persist until 2027, delaying major digital infrastructure projects.Read More

The rupee’s slide past 90 marks the latest phase in a four-decade depreciation driven by weak flows, record trade deficits, and persistent importer demand. With FPIs selling aggressively, FDI turning negative, and hedging pressures rising, the RBI is easing volatility even as structural vulnerabilities keep the currency under strain.Read More

Market strategist Sandip Sabharwal sees selective consumption opportunities despite uneven market participation, favoring steady FMCG names like Dabur and Godrej Consumer, alongside niche plays like Wonderla Holidays. He believes inflation data supports an RBI rate cut, though external commentary on the rupee may lead to caution.Read More

Meesho’s Rs 5,421-crore IPO saw a strong start, with retail investors fully subscribing within the first hour while overall subscription reached 42% by 11:20 AM. The GMP of Rs 49 signals an expected listing near Rs 160. Analysts highlight Meesho’s rapid user growth, deep Tier-2/3 penetration, improving unit economics, and positive free cash flow, though...Read More

American Bitcoin Corp. shares plunged over 50% in minutes, highlighting the collapse of Trump-linked crypto ventures. While Bitcoin and broader crypto markets fell around 25% in recent months, Trump-associated tokens and projects, including memecoins, Alt5 Sigma, and World Liberty Financial, suffered far steeper losses. The setbacks underscore the volatility of crypto markets and the waning...Read More

Bitcoin rebounded sharply from an $84,000 low to trade above $92,000 as the global crypto market cap climbed to $3.13 trillion. A surge in ETF volumes, renewed liquidity, and improved sentiment lifted major altcoins, signalling strengthening momentum despite lingering market fears.Read More

Indian government bonds saw a dip Wednesday, reversing some of Tuesday’s gains. Market speculation of Reserve Bank of India buying was countered by data showing limited purchases by the “Others” category.Read More

Pharma firm Corona Remedies, backed by ChrysCapital, has set its IPO price band at Rs 1,008-1,062, valuing the company at nearly Rs 6,500 crore. The Rs 655.37 crore public offering, an Offer For Sale, opens December 8 and closes December 10. The company, a leader in women’s healthcare and cardio-diabeto segments, aims to debut on...Read More

Inox Wind Ltd. A small mid-cap pick by Axis Securities combines a turnaround-driven recovery, improving finances and order book strength, making it a compelling call with potential upside of 43%.Read More

Analysts favor Aequs as the top IPO pick for long-term investors, citing its balance of growth, clarity, and valuation. While Meesho leads in unofficial market buzz with a higher GMP, Aequs offers tangible visibility to profitability within 12-24 months, making it a pragmatic choice for steady investors.Read More